Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C [clinicaltrials:NCT00088504]
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C [clinicaltrials:NCT00088504]
Bio2RDF identifier
NCT00088504
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00088504
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
This trial is designed ...... irus infection and treatment.
brief title [clinicaltrials_vocabulary:brief-title]
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
completion date [clinicaltrials_vocabulary:completion-date]
2006-10-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2004-07-27T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2007-12-17T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00088504
official title [clinicaltrials_vocabulary:official-title]
A Phase 2b Study of Merimepodi ...... Interferon Alfa and Ribavirin
org study id [clinicaltrials_vocabulary:org-study-id]
VX03-497-205
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2004-07-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2007-12-01T00:00:00Z
identifier
clinicaltrials:NCT00088504
title
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
@en
type
label
Merimepodib (MMPD) in Triple C ...... C [clinicaltrials:NCT00088504]
@en